1/1/2024 0 Comments Heb vaccine booster schedulerEpidemiology Disease description Infectious agent Significant revisions included in this chapter are highlighted in the Table of Updates to the Canadian Immunization Guide. Infants born to infected mothers are at highest risk of becoming chronic HB carriers.Chronic infection may lead to serious liver disease. A person with acute HB can become a chronic HB carrier and remain infectious.With few exceptions, people with indications for both hepatitis A (HA) and HB vaccine should be immunized with combined HAHB vaccine.There are many different HB-containing vaccine schedules and dosages.susceptible household and sexual contacts of an acute case or chronic carrier of HB.susceptible persons potentially exposed to blood or bodily fluids containing HB virus.Post-exposure prophylaxis (PEP) should be offered to:.Pre-exposure HB immunization is recommended for high-risk groups.Routine HB immunization is recommended for all children.Reactions to HB vaccine are generally mild and transient and include: irritability, headache, fatigue, as well as pain and redness at the injection site.HB vaccine is 95% to 100% effective pre-exposure.Infants, young children and immunocompromised persons are at highest risk of becoming chronic HB carriers.Initial infection with HB may be asymptomatic in up to 50% of adults and 90% of children. A high proportion of HB carriers in Canada are immigrants from HB-endemic areas. In Canada, most acute cases of hepatitis B (HB) occur in unimmunized household contacts of HB carriers and people 25 years of age and older who acquire infection through unprotected sexual activity, sharing injection drug equipment, or procedures with percutaneous exposure.Key Information (Refer to text for details) Storage and Handling of Immunizing Agents.Table 4: Hepatitis B immunization recommendations for preterm infants weighing less than 2,000 grams, by maternal hepatitis B surface antigen (HBsAg) status.Figure 2: Management of individuals with percutaneous or mucosal exposure to an uninfected or low risk source.Figure 1: Management of individuals with percutaneous or mucosal exposure to an infected or high risk source.Table 3: Recommended doses and schedules for hepatitis-B containing vaccines.Table 2: Recommended recipients of hepatitis B vaccine for pre-exposure prevention.Immunogenicity, Efficacy and Effectiveness.Immunizing Agents Available for Use in Canada.Table 1: Current provincial and territorial schedules for HB immunization and year of program introduction.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |